XZ-126

N/A

Report date: 2026/04/14 20:00:15
NME

Base Information

Drug NameXZ-126
Drug Alias Name注射用卡巴他赛脂质体XZ126XZ-126
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin polymerisation promotersTubulin depolymerization inhibitors
TargetsTubulin
Therapy Area/IndicationsSolid tumoursProstatic Neoplasms, Castration-Resistant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumoursProstatic Neoplasms, Castration-Resistant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A